Discordant pattern, visual identification of myocardial viability with PET;El patrón discordante, representación visual de viabilidad miocárdica con PET

Archivos de Cardiologia de Mexico

Volumn 76, Issue 4, 2006, Pages 347-354

  Alexánderson, Erick ^a,b   Ricalde, A ^b   Zeron J ^b   Talayero, J A ^b   Cruz, P ^b   Adame, G ^b   Mendoza, G ^b   Meave, A ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Discordant pattern; Myocardial viability; Positron emission tomography (PET)

Indexed keywords

AMMONIA N 13; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; DIAGNOSTIC IMAGING; HEART EJECTION FRACTION; HEART MUSCLE METABOLISM; HEART PERFUSION; HUMAN; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVASCULARIZATION;

CORONARY CIRCULATION; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HEART; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33845925575     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. RAHIMTOOLA SH: The hibernating myocardium. Am Heart J 1989; 117: 211-21.
2. WIJNS W, VATNER S, CAMICI P: Hibernating Myocardium. N Engl J Med 1998; 339(3): 173-81.
3. JIMENEZ BORREGUERO LJ, RUIZ-SALMERON R: Assessment of Myocardial Viability in Patients Before Revascularization. Rev Esp Cardiol 2003; 56(7): 721-33.
4. REDWOOD SR, FERRARI R, MARBER MS: Myocardial hibernation and stunning: From physiological principles to clinical practice. Heart 1998; 80: 218-22.
5. VANOVERSHCELDE LJ, WIJNS W, DEPRE C, ESSAMRI B, HEYNDRICKX G, BORGES M, ET AL: Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral dependent myocardium. Circulation 1993; 87: 1513-23.
6. ALEXÁNDERSON E, KERIK N, UNZEK S, FERMON S: Principios y aplicaciones de la tomografía par emisión de positrones (PET) en la cardiología. PET en México: una realidad. Arch Cardiol Mex 2002; 72: 157-64.
7. DUTKA DP, CAMICI PG: The contribution of positron emission tomography to the study of ischemic heart failure. Prog Cardiovasc Dis 2001; 43(5): 399-418.
8. SCHELBERT HR: Metabolic imaging to assess myocardial viability. J Nucl Med 1994; 35: 8S.
9. FITZGERALD J, PARKER A, DANIAS P: F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability. J Nucl Cardiol 2000; 7(4): 382-7.
10. STILLMAN AE, WILKE N, JEROSCH-HEROLD M: Myocardial Viability. Radiol. Clin North Am 1999; 37(2): 361-78.
11. BAX JJ, VEENING MA, VISSER FC, VAN LINGEN A, HEINE RJ, GOMEL JH, VISSER CA: Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur J Nucl Med. 1997; 24(1): 35-41.
12. KNUUTI, MJ, NUUTILA P, RUOTSALAINEN U, SARASTE M, HARKONEN R, AHONEN A, ET AL: Euglycemic Hyperinsulinemic Clamp and Oral Glucose Load in Stimulating Myocardial Glucose Utilization During Positron Emission Tomography. J Nucl Med, 1992; 33(7): 1255-1262.
13. Knuuti MJ, Yki-Jarvinen H, Voipio-Pulkki LM, Maki M, Ruotsalainen U, Harkonen R, Teras M, et al: Enhancement of Myocardial [Fluorine-18] Fluorodeoxyglucose Uptake By a Nicotinic Acid Derivative. J Nucl Med 1994; 35(6): 989-998.
14. VAN LINGEN A, HUIJGENS PC, VISSER FC, OSSENKOPPELE GJ, HOEKSTRA OS, MARTENS HJ, ET AL: Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. Eur J Nucl Med 1992; 19(5): 315-21.
15. SANDLER MP, BAX JJ, PATTON JA, VISSER FC, MARTIN WH, WIJNS W, ET AL: Fluorine-18- fluorodeoxyglucose cardiac imaging using a modified scintillation camera. J Nucl Med, 1998; 39(12): 2035-43.
16. BAX JJ, VISSER FC, VAN LINGEN A, HUITINK JM, KAMP O, VAN LEEUWEN GR, ET AL: Feasibility of Assessing Regional Myocardial Uptake of F-18-Fluorodeoxyglucose Using Single Photon Emission Computed Tomography. Eur Heart J 1993; 14(12): 1675-1682.
17. BAX JJ, VISSER FC, VAN LINGEN A, GROENEVELD AB, HUITINK JM, TEULE GJ, ET AL: Relation Between Myocardial Uptake of Thallium-201 Chloride and Fluorine-18 Fluorodeoxyglucose Imaged With Single-Photon Emission Tomography in Normal Individuals. Eur J Nucl Med 1995; 22(1): 56-60.
18. SANDLER MP, VIDELEFSKY S, DELBEKE D, PATTON JA, MEYEROWITZ C, MARTIN WH, ET AL: Evaluation of myocardial ischemia using a rest metabolism/ stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol, 1995, 26(4): 870-8.
19. MARTIN WH, DELBEKE D, PATTON JA, HENDRIX B, WEINFELD Z, OHANA I, ET AL: FDC-SPECT: correlation with FDG-PET. J Nucl Med 1995; 36(6): 988-95.
20. STOLL HP, HELLWIG N, ALEXANDER C, OZBEK C, SCHIEFFER H, OBERHAUSEN E: Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography. Eur J Nucl Med. 1994; 21(10): 1085-93.
21. BAX JJ, VALKEMA R, VISSER FC, VAN LINGEN A, CORNEL JH, POLDERMANS D, ET AL: FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo. Eur Heart J 1997; 18(Suppl D): D124-9.
22. DELBEKE D, VIDELEFSKY S, PATTON JA, CAMPBELL MG, MARTIN WH, OHANA I, ET AL: Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG. J Nucl Med 1995; 36(11): 2110-9.
23. BURT RW, PERKINS OW, OPPENHEIM BE, SCHAUWECKER DS, STEIN L, WELLMAN HN, ET AL: Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med 1995; 36(2): 176-9.
24. BAX JJ, CORNEL JH, VISSER FC, FIORETTI PM, VAN LINGEN A, REIJS AE, ET AL: Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/ thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28(3): 558-64.
25. SRINIVASAN G, KITSIOU AN, BACHARACH SL, BARTLETT ML, MILLER-DAVIS C, DILSIZIAN V: [F-18] fluorodeoxyglucose single photon emission computed tomography: Can it replace PET and thallium SPECT for the assessment of myocardial tomography? Circulation 1998; 97(9): 843-850.
26. CHEN EQ, MACINTYRE WJ, Go RT, BRUNKEN RC, SAHA GB, WONG CY, ET AL: Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET. J Nucl Med 1997; 38(4): 582-6.
27. USSELL RR, MRUS JM, MOMMESSIN JI, TAEGTMEYER H: Compartmentation of hexokinase in rat heart. J Clin Invest 1992; 90: 1972-1977.
28. TAEGTMEYER H, MCNULTY P, YOUNG M: Adaptation and maladaptation of the heart in diabetes. Circulation 2002; 105: 1727-1733.
29. RUDERMAN NB, SAHA AK, VAVVAS D, WITTERS LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 1999; 276: E1-E18.
30. SAHA AK, VAVVAS D, KUROWSKI TG, APAZIDIS A, WITTERS LA, SHAFRIR E ET AL: Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. Am J Physiol 1997; 272: E641-E648.
31. CALVANI M, REDA E, ARRIGONI-MARTELLI E: Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol 2000; 95: 75-83.
32. ALEXANDERSON E, GOMEZ-MARTIN D, BENITO I, RUIZ-RAMIREZ L, RICALDE A, MEAVE A: Tomografía par emisión de positrones (PET): Una herramienta útil para el estudio del metabolismo cardíaco. Arch Cardiol Mex 2004; 74: 220-228.
33. BROSIUS FC, LIU Y, NGUYEN N, SUN D, BARTLETT J, SCHWAIGER M. Persistent myocardial ischemia increases GLUT 1 glucose transporter expression in both ischemic and non-ischemic heart regions. J Mol Cell Cardiol 1997; 29(6): 1675-85.
34. YOUNG LH, RENFU Y, RUSSELL R, HU X, CAPLAN M, REN J, SHULMAN GI, SINUSAS AJ: Low-flow ischemia leads to translocation of canine heart GLUT 4 and GLUT 1 glucose transporters to the sarcolemma in vivo. Circulation 1997; 95: 415-422.
35. LOPASCHUK G, STANLEY W. Glucose metabolism in the Ischemic Heart. Circulation 1997; 95: 313-315.
36. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH: Sensitivity, specificity and predictive accuracies of various non-invasive techniques for hibernating myocardium. Curr Probl Cardiol 2001; 26(2): 141-6.
37. BAX JJ, VISSER FC, ELHENDY A, POLDERMANS D, CORNEL JH, VAN LINGEN A, ET AL: Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria. J Nucl Med 1999; 40(11): 1866-73.
38. LUCIGNANI G, PAOLINI G, LANDONI C, ZUCCARI M, PAGANELLI G, GALLI L, ET AL: Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992; 19(10): 874-81.
39. TILLISCH J, BRUNKEN R, MARSHALL R, SCHWAIGER M, MANDELKERN M, PHELPS M, ET AL: Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314(14): 884-8.
40. DEPRE C, VANOVERSCHELDE JL, MELIN JA, BORGERS M, BOL A, AUSMA J, ET AL: Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995; 268(3 Pt 2): H1265-75.
41. DI CARLI MF, DAVIDSON M, LITTLE R, KHANNA S, MODY FV, BRUNKEN RC, ET AL: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73(8): 527-33.
42. PAOLINI G, LUCIGNANI G, ZUCCARI M, LANDONI C, VANOLI G, DI CREDICO G, ET AL: Identification and revascularization of hibernating myocardium in angina-free patients with left ventricular dysfunction. Eur J Cardiothorac Surg 1994; 8(3): 139-44.
43. EITZMAN D, AL-AOUAR Z, KANTER HL, VOM DAHL J, KIRSH M, DEEB GM, ET AL: Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 20(3): 559-65.
44. DI CARLI M, CZERNIN J, HOH CK, GERBAUDO VH, BRUNKEN RC, HUANG SC, ET AL: Relation Among Stenosis Severity, Myocardial Blood Flow, and Flow Reserve in Patients With Coronary Artery Disease. Circulation 1995; 91(7): 1944-1951.
45. BAX JJ, VISSER FC, POLDERMANS D, ELHENDY A, CORNEL JH, BOERSMA E, ET AL: Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 2001; 42(1): 79-86.
46. YOSHIDA K, GOULD KL: Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993; 22(4): 984-97.
47. LEE KS, MARWICK TH, COOK SA, GO RT, FIX JS, JAMES KB, ET AL: Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994; 90(6): 2687-94.
48. DI CARLI MF: Predicting improved function after myocardial revascularization. Curr Opinions Cardiol 1998; 13(6): 415-24.
49. DUONG T, HENDI P, FONAROW G, ASGARZADIE F, STEVENSON L, DI CARLI M, ET AL: Role of positron emission tomographic assesment of myocardial viability in the management of patients who are referred for cardiac transplantation. Circulation 1995; 92(8): 1-123.